Medicare Enrolled

Dr. Robert Larson, M.D.

Family Medicine · Kent, WA
Low-engagement
26004 104TH AVE SE, Kent, WA 98030
4252514040
In practice since 2006 (19 years)
NPI: 1881617488 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Larson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Larson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Larson

Dr. Robert Larson is a family medicine specialist in Kent, WA, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Larson received a total of $9,114 from 49 pharmaceutical and/or device companies across 533 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Larson is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $9,114 industry payments

Industry Payment Transparency

Open Payments through 2022 ↗
$9,114
Total received (2018-2022)
Avg $1,823/year across 5 years
Top 3% in WA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
533
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,936 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$178 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$1,305
2021
$2,125
2020
$1,652
2019
$1,888
2018
$2,143

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$183
E.R. Squibb & Sons, L.L.C.
$133
Biohaven Pharmaceutical Holding Company Ltd.
$110
Janssen Pharmaceuticals, Inc
$109
Lilly USA, LLC
$97
SANOFI-AVENTIS U.S. LLC
$90
ABBVIE INC.
$86
Merck Sharp & Dohme LLC
$83
Novo Nordisk Inc
$71
AstraZeneca Pharmaceuticals LP
$65
Takeda Pharmaceuticals U.S.A., Inc.
$52
PFIZER INC.
$45
Organon LLC
$30
Bayer HealthCare Pharmaceuticals Inc.
$30
Aspira Women's Health Inc
$26
Novartis Pharmaceuticals Corporation
$24
GlaxoSmithKline, LLC.
$24
Otsuka America Pharmaceutical, Inc.
$22
Xeris Pharmaceuticals, Inc.
$15
Coala Life Inc
$13
Top 3 companies account for 32.6% of 2022 payments
All-time payments by company (2018-2022) ›
Amgen Inc.
$1,300
Janssen Pharmaceuticals, Inc
$957
PFIZER INC.
$880
AstraZeneca Pharmaceuticals LP
$758
Takeda Pharmaceuticals U.S.A., Inc.
$564
Lilly USA, LLC
$499
Novo Nordisk Inc
$367
Merck Sharp & Dohme Corporation
$343
Novartis Pharmaceuticals Corporation
$325
GlaxoSmithKline, LLC.
$292
SANOFI-AVENTIS U.S. LLC
$250
Boehringer Ingelheim Pharmaceuticals, Inc.
$242
AbbVie Inc.
$240
E.R. Squibb & Sons, L.L.C.
$230
Biohaven Pharmaceuticals, Inc.
$158
Eisai Inc.
$141
Amarin Pharma Inc.
$125
Esperion Therapeutics, Inc.
$116
Biohaven Pharmaceutical Holding Company Ltd.
$110
AbbVie, Inc.
$105
Ironwood Pharmaceuticals, Inc
$91
ABBVIE INC.
$86
Merck Sharp & Dohme LLC
$83
Daiichi Sankyo Inc.
$82
Philips Electronics North America Corporation
$81
Avanir Pharmaceuticals, Inc.
$58
Hologic, LLC
$56
Teva Pharmaceuticals USA, Inc.
$55
Organon LLC
$51
Antares Pharma, Inc.
$46
Allergan Inc.
$45
Coala Life Inc
$40
SANOFI PASTEUR INC.
$34
Bayer HealthCare Pharmaceuticals Inc.
$30
Astellas Pharma US Inc
$28
Aspira Women's Health Inc
$26
BOSTON SCIENTIFIC CORPORATION
$25
Roche Diagnostics Corporation
$24
Otsuka America Pharmaceutical, Inc.
$22
Ultragenyx Pharmaceutical Inc.
$21
Circassia Pharmaceuticals Inc
$19
Seqirus USA Inc
$18
Assertio Therapeutics, Inc.
$17
BioDelivery Sciences International, Inc.
$16
Xeris Pharmaceuticals, Inc.
$15
Exeltis, USA Inc.
$12
Mylan Specialty L.P.
$12
Shire North American Group Inc
$11
Allergan, Inc.
$11
Top 3 companies account for 34.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ABILIFY MAINTENA · ADACEL · AIMOVIG · AJOVY · APTIMA · Aimovig · BELSOMRA · BEXSERO · BREZTRI · BREZTRI AEROSPHERE · BUNAVAIL 2.1 mg 30-count box · BYDUREON · CHANTIX · CINtec PLUS Cytology · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMBIVENT RESPIMAT · Coala Heart Monitor · DUAKLIR PRESSAIR · DUZALLO · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FORTEO · Flucelvax · GARDASIL 9 · GVOKE PFS · Humira · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LINZESS · LYRICA · Linzess · MYRBETRIQ · NEXLETOL · NEXLIZET · NEXPLANON · NO PRODUCT DISCUSSED · NUEDEXTA · NURTEC ODT · Nucynta · OVA1 · Otezla · Ozempic · PNEUMOVAX 23 · PREMARIN · PREVNAR 13 · Ponvory · Prolia · QULIPTA · ROTATEQ · Repatha · Respiratoriy Care Undiv · Rinvoq · Rybelsus · SHINGRIX · SLYND · SOLIQUA · SOLIQUA 100/33 · SYMBICORT · THINPREP 2000 PROCESSOR · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Thinprep · Tresiba · Trintellix · UBRELVY · VERQUVO · VRAYLAR · VYVANSE · Vascepa · Victoza · Vyvanse · WATCHMAN · Wellcentive Undiv · XARELTO · XIGDUO · XYOSTED · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in WA.

Looking for a family medicine specialist in Kent?
Compare family medicine physicians in the Kent area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,152
Per 100K population
95.1
County median income
$122,148
Nearest hospital
MULTICARE COVINGTON MEDICAL CENTER
3.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Larson is a family medicine specialist, with low-engagement industry engagement in the top 3% of WA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Larson receive payments from pharmaceutical companies?
Yes. Dr. Larson received a total of $9,114 from 49 companies across 533 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Larson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →